Chapter 7: Role of Cyclodextrins in Nanoparticle-Based Systems for Drug Delivery

Posted by

This chapter reviews major critical research on cyclodextrin-based nanoparticles to explain their versatility and high potential for advanced drug delivery, protein and peptide drug delivery, and gene delivery. This chapter also highlights the role of cyclodextrins in specific types of nanoparticles such as gold, silver, and magnetic, polymeric, and lipid-based nanoparticles. Finally, pharmaceutical applications of amphiphilic cyclodextrin nanoparticles and miscellaneous administration routes of cyclodextrin-based nanoparticles are also discussed.

Nanoparticles overcome the drawbacks associated with conventional formulations such as prolong release and site-specific action of active molecules. Cyclodextrins and chemically altered cyclodextrins in combination with certain polymers have sparked various researchers for exceptional advancements in the field of novel drug delivery. More recently, these substances have been incorporated in polymer systems to develop nanoparticles. Cyclodextrin conjugated nanoparticles offer synergistic advantages such as enhanced drug solubility, served as drug carriers to a specific target site such as cancer cells with minimum toxicity to normal cells, greater surface area over microparticles, and higher stability over liposomes. Accordingly, nanoparticles based on cyclodextrins have gained notable interest, and a variety of nanoparticles have been developed since the last two decades.

Pandey, A. (2020) Role of Cyclodextrins in Nanoparticle-Based Systems for Drug Delivery. In: Crini, G., Forurmentin, S., Lichtfouse, E. (eds.) The History of Cyclodextrins. Springer, New York. pp. 305-343.


Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.